208 related articles for article (PubMed ID: 22484226)
41. Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil. Ludwig-McGill Study Group.
Franco E; Villa L; Rohan T; Ferenczy A; Petzl-Erler M; Matlashewski G
Rev Panam Salud Publica; 1999 Oct; 6(4):223-33. PubMed ID: 10572472
[TBL] [Abstract][Full Text] [Related]
42. MBL2 gene polymorphisms are correlated with high-risk human papillomavirus infection but not with human papillomavirus-related cervical cancer.
Segat L; Crovella S; Comar M; Milanese M; Zanotta N; Fabris A; Trevisiol C; Rossi T; De Seta F; Campello C
Hum Immunol; 2009 Jun; 70(6):436-9. PubMed ID: 19275921
[TBL] [Abstract][Full Text] [Related]
43. Germline genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes in Indian cervical cancer: associations with tumor progression, age and human papillomavirus infection.
Joseph T; Chacko P; Wesley R; Jayaprakash PG; James FV; Pillai MR
Gynecol Oncol; 2006 Jun; 101(3):411-7. PubMed ID: 16360200
[TBL] [Abstract][Full Text] [Related]
44. Human papillomavirus, it's genes...and cancer vaccines.
Steller MA
Cancer Cell; 2003 Jan; 3(1):7-8. PubMed ID: 12559170
[TBL] [Abstract][Full Text] [Related]
45. HPV epigenetic mechanisms related to Oropharyngeal and Cervix cancers.
Di Domenico M; Giovane G; Kouidhi S; Iorio R; Romano M; De Francesco F; Feola A; Siciliano C; Califano L; Giordano A
Cancer Biol Ther; 2018; 19(10):850-857. PubMed ID: 28362190
[TBL] [Abstract][Full Text] [Related]
46. Interaction between susceptibility loci in cGAS-STING pathway, MHC gene and HPV infection on the risk of cervical precancerous lesions in Chinese population.
Xiao D; Huang W; Ou M; Guo C; Ye X; Liu Y; Wang M; Zhang B; Zhang N; Huang S; Zang J; Zhou Z; Wen Z; Zeng C; Wu C; Huang C; Wei X; Yang G; Jing C
Oncotarget; 2016 Dec; 7(51):84228-84238. PubMed ID: 27705945
[TBL] [Abstract][Full Text] [Related]
47. Cis-regulatory effect of HPV integration is constrained by host chromatin architecture in cervical cancers.
Singh AK; Walavalkar K; Tavernari D; Ciriello G; Notani D; Sabarinathan R
Mol Oncol; 2024 May; 18(5):1189-1208. PubMed ID: 38013620
[TBL] [Abstract][Full Text] [Related]
48. The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections.
Lazarczyk M; Cassonnet P; Pons C; Jacob Y; Favre M
Microbiol Mol Biol Rev; 2009 Jun; 73(2):348-70. PubMed ID: 19487731
[TBL] [Abstract][Full Text] [Related]
49. Prognostic and therapeutic potential of STAT3: Opportunities and challenges in targeting HPV-mediated cervical carcinogenesis.
Janjua D; Thakur K; Aggarwal N; Chaudhary A; Yadav J; Chhokar A; Tripathi T; Joshi U; Senrung A; Bharti AC
Crit Rev Oncol Hematol; 2024 May; 197():104346. PubMed ID: 38608913
[TBL] [Abstract][Full Text] [Related]
50. Human papillomavirus infection and the multistage carcinogenesis of cervical cancer.
Schiffman M; Wentzensen N
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):553-60. PubMed ID: 23549399
[TBL] [Abstract][Full Text] [Related]
51. Qualitative and quantitative changes in mitochondrial DNA associated with cervical cancer: A comprehensive review.
Pereira IOA; Silva NNT; Lima AA; da Silva GN
Environ Mol Mutagen; 2024; 65(3-4):143-152. PubMed ID: 38523463
[TBL] [Abstract][Full Text] [Related]
52. Cervical cancer development, chemoresistance, and therapy: a snapshot of involvement of microRNA.
Mitra T; Elangovan S
Mol Cell Biochem; 2021 Dec; 476(12):4363-4385. PubMed ID: 34453645
[TBL] [Abstract][Full Text] [Related]
53. The functions of lncRNAs in the HPV-negative cervical cancer compared with HPV-positive cervical cancer.
Liu Y; Liu H; Sheng B; Pan S; Wang ZW; Zhu X
Apoptosis; 2022 Oct; 27(9-10):685-696. PubMed ID: 35980559
[TBL] [Abstract][Full Text] [Related]
54. Genome-wide association study and functional follow-up identify 14q12 as a candidate risk locus for cervical cancer.
Ramachandran D; Dennis J; Fachal L; Schürmann P; Bousset K; Hülse F; Mao Q; Wang Y; Jentschke M; Böhmer G; Strauß HG; Hirchenhain C; Schmidmayr M; Müller F; Runnebaum I; Hein A; Stübs F; Koch M; Ruebner M; Beckmann MW; Fasching PA; Luyten A; Dürst M; Hillemanns P; Easton DF; Dörk T
Hum Mol Genet; 2022 Aug; 31(15):2483-2497. PubMed ID: 35157032
[TBL] [Abstract][Full Text] [Related]
55. Genome-wide association study of cervical cancer suggests a role for ARRDC3 gene in human papillomavirus infection.
Takeuchi F; Kukimoto I; Li Z; Li S; Li N; Hu Z; Takahashi A; Inoue S; Yokoi S; Chen J; Hang D; Kuroda M; Matsuda F; Mizuno M; Mori S; Wu P; Tanaka N; Matsuo K; Kamatani Y; Kubo M; Ma D; Shi Y
Hum Mol Genet; 2019 Jan; 28(2):341-348. PubMed ID: 30412241
[TBL] [Abstract][Full Text] [Related]
56. Defective antioxidant systems in cervical cancer.
Jiang B; Xiao S; Khan MA; Xue M
Tumour Biol; 2013 Aug; 34(4):2003-9. PubMed ID: 23616011
[TBL] [Abstract][Full Text] [Related]
57. Stability analysis and optimal control of HPV infection model with early-stage cervical cancer.
Allali K
Biosystems; 2021 Jan; 199():104321. PubMed ID: 33285251
[TBL] [Abstract][Full Text] [Related]
58. A comprehensive review on host genetic susceptibility to human papillomavirus infection and progression to cervical cancer.
Chattopadhyay K
Indian J Hum Genet; 2011 Sep; 17(3):132-44. PubMed ID: 22345983
[TBL] [Abstract][Full Text] [Related]
59. Like Brothers in Arms: How Hormonal Stimuli and Changes in the Metabolism Signaling Cooperate, Leading HPV Infection to Drive the Onset of Cervical Cancer.
Läsche M; Gallwas J; Gründker C
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563441
[TBL] [Abstract][Full Text] [Related]
60. HPV and HPV-associated cancer.
Liu X; Wallace N
J Med Virol; 2023 Oct; 95(10):e29177. PubMed ID: 37842777
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
